BioAtla, Inc. (BCAB)
OTCMKTS · Delayed Price · Currency is USD
1.080
-0.610 (-36.09%)
At close: Sep 1, 2026
BioAtla Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -31.45 | -59.61 | -69.78 | -123.46 | -106.48 | -95.4 |
Depreciation & Amortization | 0.2 | 0.37 | 0.93 | 1.22 | 1.2 | 1.33 |
Loss (Gain) From Sale of Assets | 0.19 | 0.19 | - | 0 | 0.01 | 0 |
Stock-Based Compensation | 3.99 | 5.43 | 8.92 | 13.54 | 14.56 | 25.12 |
Other Operating Activities | -1.14 | 0.45 | -0.81 | - | - | -0.69 |
Change in Accounts Payable | 3.66 | 2.8 | -13.46 | 5.28 | 3.41 | 7.99 |
Change in Other Net Operating Assets | 3.09 | 2.16 | 2.26 | -0.6 | -3.12 | -0.57 |
Operating Cash Flow | -23.48 | -48.2 | -71.94 | -104.02 | -90.42 | -62.21 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | -0.1 | -0.27 | -0.92 |
Sale of Property, Plant & Equipment | - | - | - | - | 0 | - |
Investing Cash Flow | - | - | - | -0.1 | -0.27 | -0.92 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 7.13 | - | - | - | - |
Net Debt Issued (Repaid) | 7.13 | 7.13 | - | - | - | - |
Issuance of Common Stock | 0.47 | 0.1 | 9.56 | 0.34 | 61.97 | 71.42 |
Repurchase of Common Stock | -0.03 | -0.05 | -0.05 | -0.26 | -0.76 | - |
Other Financing Activities | -0.74 | -0.9 | - | - | - | -1.91 |
Financing Cash Flow | 6.82 | 6.28 | 9.51 | 0.08 | 61.21 | 69.51 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -16.66 | -41.93 | -62.43 | -104.04 | -29.47 | 6.37 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -23.48 | -48.2 | -71.94 | -104.11 | -90.69 | -63.14 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -276.26% | -2410.20% | -653.96% | - | - | -25255.20% |
Free Cash Flow Per Share | -16.97 | -40.97 | -74.05 | -108.96 | -116.48 | -91.34 |
Levered Free Cash Flow | -11.86 | -22.8 | -46.64 | -61.29 | -51.52 | -48.83 |
Unlevered Free Cash Flow | -11.86 | -22.8 | -46.64 | -61.29 | -51.52 | -48.83 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Change in Working Capital | 4.74 | 4.96 | -11.2 | 4.68 | 0.29 | 7.42 |